✦ LIBER ✦

Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP)

✍ Scribed by R. Swords; D. Power; M. Fay; R. O'Donnell; P.T. Murphy

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 59 KB
Volume: 77
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.20135

No coin nor oath required. For personal study only.

✦ Synopsis

Letters to the Editor are utilized to communicate a single novel observation or finding. Correspondence is to be used to supplement or constructively comment on the contents of a publication in the journal and cannot exceed the restrictions for Letters to the Editor. The Editor reserves the right to shorten text, delete objectional comments, and make other changes to comply with the style of the journal. Permission for publication must be appended as a postscript.

📜 SIMILAR VOLUMES

Long term follow-up after splenectomy pe

Long term follow-up after splenectomy performed for immune thrombocytopenic purpura (ITP)

✍ Joseph Schwartz; Melissa D. Leber; Shmuel Gillis; Austin Giunta; Amiram Eldor; J 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 2 views

Successful treatment with rituximab for

Successful treatment with rituximab for relapsing immune thrombocytopenic purpura (ITP) associated with low-grade non-Hodgkin's lymphoma

✍ Lev Shvidel; Abraham Klepfish; Alain Berrebi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB 👁 1 views

Rituximab therapy for thrombotic thrombo

Rituximab therapy for thrombotic thrombocytopenic purpura: A proposed study of the Transfusion Medicine/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders

✍ James N. George; Robert D. Woodson; Joseph E. Kiss; Kiarash Kojouri; Sara K. Ves 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract The rationale for immunosuppressive therapy of thrombotic thrombocytopenic purpura (TTP) was established by observations that TTP may be caused by autoantibodies to ADAMTS13. Patients with high‐titer autoantibodies to ADAMTS13 may have a higher mortality, and survivors may require prolo